2016-03-03T00:00:00.000-05:00
position,0.402172
Exchange Commission,0.388602
EQIS Capital Management,0.366411
Celgene Co.,-0.208006
52-week low,-0.756433
quarter worth,0.398548
integrated biopharmaceutical company,0.302063
strong buy rating,0.264384
Russell Frank,0.588524
Boston Advisors,0.440401
Co. Inc.,0.398548
Vontobel Asset Management,0.47958
recent quarter,0.771253
stock,0.362273
consensus price target,0.439832
recent filing,0.388602
Eagle Asset Management,0.40925
Morgens Waterfall Vintiadis,0.398548
InvestorPlace Broker Center,0.555736
biopharmaceutical company,0.399541
sell rating,0.33019
Zacks Investment Research,0.254592
personal trading style,0.598412
average rating,-0.253646
research note,0.365588
Celgene,-0.260661
Equities analysts,-0.627448
average price,0.117846
shares,0.187791
concise daily summary,0.449296
stock broker,0.245696
mid-day trading,-0.471601
new position,0.398548
equities research analyst,0.33019
quarter,0.0597455
